SLT Holdings’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Other funds holding GNOM
SLT Holdings's GNOM Position: Q2 2026 in Review
SLT Holdings opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q2 2026: 11,000 shares worth $625K. The stake represents 0.39% of the portfolio and ranks #63 among its holdings.
2 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.
- SLT Holdings held 11,000 shares of Global X Genomics & Biotechnology ETF worth $625K as of Q2 2026.
- Global X Genomics & Biotechnology ETF was a new SLT Holdings position in Q2 2026.
- Global X Genomics & Biotechnology ETF made up 0.39% of SLT Holdings's portfolio in Q2 2026, its #63 holding.
- 2 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.
Based on SLT Holdings's 13F filing for Q2 2026, filed 17 Jul 2026.